Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLOXY-1: Oxytocin for Glucose Regulation
NCT06334172Recruiting
- Sponsor
- Gentofte Hospital
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in diabetes mellitus (DM) (3 arms), sponsored by Gentofte Hospital. Primary endpoint: Insulin secretion - c-peptide. Started Jan 2024; status: recruiting.
02
Drugs
oxytocin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06334172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334172.